Cargando…
Annexin 1 and Melanocortin Peptide Therapy for Protection Against Ischaemic-Reperfusion Damage in the Heart
Cardiovascular disease is a major cause of mortality within the western world affecting 2.7 million British people. This review highlights the beneficial effects of naturally occurring hormones and their peptides, in myocardial ischaemic-injury (MI) models, a disease pathology in which cytokines and...
Autores principales: | Gavins, F.N.E., Leoni, G., Getting, S.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917400/ https://www.ncbi.nlm.nih.gov/pubmed/16937007 http://dx.doi.org/10.1100/tsw.2006.196 |
Ejemplares similares
-
Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion
por: Leoni, Giovanna, et al.
Publicado: (2008) -
Melanocortin Peptide Therapy for the Treatment of Arthritic Pathologies
por: Getting, S. J., et al.
Publicado: (2009) -
Glucocorticoid and Melanocortins: Special Issue
por: Getting, Stephen J.
Publicado: (2007) -
Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury
por: Ansari, Junaid, et al.
Publicado: (2018) -
Annexin A1 and the regulation of innate and adaptive immunity
por: Gavins, Felicity N. E., et al.
Publicado: (2012)